Literature DB >> 12493278

Mild cognitive impairment in older people.

Alistair Burns1, Michael Zaudig.   

Abstract

CONTEXT: As public awareness of Alzheimer's disease increases, more people are asking for help and advice about memory problems. Memory complaints may be secondary to psychiatric, psychological, and physical conditions and is an almost universal early symptom of dementia. The concept of amnestic mild cognitive impairment attempts to describe those people in whom memory loss is not of such severity to merit a diagnosis of dementia. The importance of this group of people is not just the need to develop interventions which ameliorate individual suffering but that they represent a population at high risk of developing dementia, especially Alzheimer's disease, and are an appropriate target for dementia prevention strategies. STARTING POINT: K Kantarci and colleagues (Dement Geriatr Cogn Disord 2002; 14: 198-207) looked at the diagnostic accuracy of magnetic-resonance hippocampal volumetry and spectroscopy in patients with mild cognitive impairment, in normal older people, and in patients with Alzheimer's disease. Hippocampal volumes and N-acetyl aspartate/creatine spectroscopy were the most sensitive assessments discriminating people with mild cognitive impairment from Alzheimer's disease. Combination assessments were better at discriminating these two groups from normal controls. The histological underpinning of cognitive symptoms in older people has been demonstrated by the Cognitive Function and Ageing study (Lancet 2001; 357: 169-75), which showed that a third of people with no clinical evidence of dementia had histopathological hallmarks of Alzheimer's disease. WHERE NEXT? 25 million people across the world have dementia. Mild cognitive impairment, if a validated concept, represents an opportunity for preventing dementia. As more information becomes available about the cause of Alzheimer's disease and prospects emerge for prevention, identification of predementia states offers considerable scope to reduce the individual and societal cost of the illness. Continued validation of the criteria for mild cognitive impairment and studies of intervention should be a priority. As more evidence becomes available highlighting the relatively arbitrary nature of dementia diagnosis (based largely on interference with activities) and interventions become available for the prevention of dementia, mild cognitive impairment and related conditions will become more important.

Entities:  

Mesh:

Year:  2002        PMID: 12493278     DOI: 10.1016/S0140-6736(02)11920-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  46 in total

1.  Mild Cognitive Impairment and Changes in Everyday Function Over Time: The Importance of Evaluating Both Speed and Accuracy.

Authors:  Caroline L Lassen-Greene; Kayla Steward; Ozioma Okonkwo; Ellen Porter; Michael Crowe; David E Vance; H Randall Griffith; Karlene Ball; Daniel C Marson; Virginia G Wadley
Journal:  J Geriatr Psychiatry Neurol       Date:  2017-07       Impact factor: 2.680

Review 2.  Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease.

Authors:  F Portet; P J Ousset; P J Visser; G B Frisoni; F Nobili; Ph Scheltens; B Vellas; J Touchon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-20       Impact factor: 10.154

3.  Modifying roles of glutathione S-transferase polymorphisms on the association between cumulative lead exposure and cognitive function.

Authors:  Ki-Do Eum; Florence T Wang; Joel Schwartz; Craig P Hersh; Karl Kelsey; Robert O Wright; Avron Spiro; David Sparrow; Howard Hu; Marc G Weisskopf
Journal:  Neurotoxicology       Date:  2013-08-16       Impact factor: 4.294

4.  A review of neuroimaging biomarkers of Alzheimer's disease.

Authors:  Tinu Varghese; R Sheelakumari; Jija S James; Ps Mathuranath
Journal:  Neurol Asia       Date:  2013       Impact factor: 0.183

5.  Predictors of cognitive complaints in older adults: a mixture regression approach.

Authors:  Matthias Kliegel; Daniel Zimprich
Journal:  Eur J Ageing       Date:  2005-03-04

6.  Lower Plasma Vitamin B-6 is Associated with 2-Year Cognitive Decline in the Boston Puerto Rican Health Study.

Authors:  Natalia Palacios; Tammy Scott; Neha Sahasrabudhe; Xiang Gao; Katherine L Tucker
Journal:  J Nutr       Date:  2019-04-01       Impact factor: 4.798

7.  Gender-specificities in Alzheimer's disease and mild cognitive impairment.

Authors:  U Beinhoff; H Tumani; J Brettschneider; D Bittner; M W Riepe
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

8.  Food Insecurity Is Associated with Subsequent Cognitive Decline in the Boston Puerto Rican Health Study.

Authors:  Janice C Wong; Tammy Scott; Parke Wilde; Yin-Ge Li; Katherine L Tucker; Xiang Gao
Journal:  J Nutr       Date:  2016-07-27       Impact factor: 4.798

9.  Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment.

Authors:  Tzvi Dwolatzky; Victor Whitehead; Glen M Doniger; Ely S Simon; Avraham Schweiger; Dena Jaffe; Howard Chertkow
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 10.  Antioxidant treatment in Alzheimer's disease: current state.

Authors:  Yossi Gilgun-Sherki; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.